Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Wagner

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Pharmacogenomics|February 27, 2013
Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traitsMichael J Wagner
Personalized Medicine|March 2, 2010
Pharmacogenetics and personal genomesMichael J Wagner
Nano Letters|May 3, 2013
Air- and water-stable gold-coated gadolinium metal nanocrystalsChao Yan, Michael J Wagner
Frontiers in Oncology|February 6, 2013
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancerMichael J Wagner, Robert G Maki
Journal of the American Chemical Society|January 9, 2003
Synthesis of sodium tantalate nanorods by alkalide reductionJennifer A Nelson, Michael J Wagner
Pharmacogenomics|August 4, 2012
Replication study of CYP4F2 association with warfarin response in an Israeli populationAlison A Motsinger-Reif, Michael J Wagner
Pharmacogenomics|June 9, 2012
Clinical trial evidence of the promise of pharmacogenomics warfarin dosing algorithmsAlison A Motsinger-Reif, Michael J Wagner
Genome Medicine|July 11, 2020
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencingAmélie Boichard, Michael J Wagner, Razelle Kurzrock
Journal for Immunotherapy of Cancer|June 4, 2021
Targeting cancer testis antigens in synovial sarcomaGeoffrey Mitchell, Seth M Pollack, Michael J Wagner
Journal of Cardiothoracic and Vascular Anesthesia|May 18, 2012
A right atrial mass in a patient with metastatic melanoma and prostate cancerBryan G Maxwell, Matthew Forrester, Michael J Wagner
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Pharmacogenomics|February 27, 2013
Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traitsMichael J Wagner
Personalized Medicine|March 2, 2010
Pharmacogenetics and personal genomesMichael J Wagner
Nano Letters|May 3, 2013
Air- and water-stable gold-coated gadolinium metal nanocrystalsChao Yan, Michael J Wagner
Frontiers in Oncology|February 6, 2013
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancerMichael J Wagner, Robert G Maki
Journal of the American Chemical Society|January 9, 2003
Synthesis of sodium tantalate nanorods by alkalide reductionJennifer A Nelson, Michael J Wagner
Pharmacogenomics|August 4, 2012
Replication study of CYP4F2 association with warfarin response in an Israeli populationAlison A Motsinger-Reif, Michael J Wagner
Pharmacogenomics|June 9, 2012
Clinical trial evidence of the promise of pharmacogenomics warfarin dosing algorithmsAlison A Motsinger-Reif, Michael J Wagner
Genome Medicine|July 11, 2020
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencingAmélie Boichard, Michael J Wagner, Razelle Kurzrock
Journal for Immunotherapy of Cancer|June 4, 2021
Targeting cancer testis antigens in synovial sarcomaGeoffrey Mitchell, Seth M Pollack, Michael J Wagner
Journal of Cardiothoracic and Vascular Anesthesia|May 18, 2012
A right atrial mass in a patient with metastatic melanoma and prostate cancerBryan G Maxwell, Matthew Forrester, Michael J Wagner
Pageof 12